FindTrial
Sign In

Diagnostic value of procalcitonin for bacterial infection in acute exacerbations of bronchiectasis

Diagnostic value of procalcitonin for bacterial infection in acute exacerbations of bronchiectasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-16008934
Enrollment
Unknown
Registered
2016-07-28
Start date
2016-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Interventions

Case series:Nil

Sponsors

Laiwu City People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Bronchiectasis was diagnosed by high-resolution computed tomography based on the criteria published by McShane PJ et al.; 2. Acute exacerbations of bronchiectasis; 3. Aged 18 years and more; 4. Procalcitonin been detected after admission.

Exclusion criteria

Exclusion criteria: 1. Associated with chronic obstructive pulmonary disease; 2. Associated with asthma; 3. Traction bronchiectasis caused by pulmonary fibrosis; 4. Rule out other possible cause procalcitonin increased diseases such as cancer, connective tissue disease, active tuberculosis, chronic liver disease and respiratory system than the bacterial infection; 5. Clinical data were incomplete; 6. Can not follow up with the person.

Design outcomes

Primary

MeasureTime frame
procalcitonin;—

Countries

China

Contacts

Public ContactZhou Yufa

Laiwu City People's Hospital

qiqianqlh@126.com+86 13963457090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026